Trade experts said that the proposal – which will form the basis for negotiations – has clearly provided a window for technology and know-how sharing, which is a major concern with suggestions that patent waiver alone will not result in production of vaccines or drugs.
Posted from: this blog via Microsoft Power Automate.
